Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 8,260 | 21,675 | 8,765 | 16,419 | 12,418 |
| Cost of Goods | 2,978 | 3,539 | 3,659 | 6,792 | 4,643 |
| Gross Profit | 5,282 | 18,136 | 5,106 | 9,627 | 7,775 |
| Operating Expenses | 20,041 | 18,280 | 19,626 | 20,323 | 19,420 |
| Operating Income | -13,781 | 395 | -13,861 | -9,904 | -11,002 |
| Interest Expense | 2,778 | 2,747 | 2,771 | 2,803 | 2,652 |
| Other Income | 8 | 18 | 102 | 71 | -4,758 |
| Pre-tax Income | -16,551 | -2,334 | -16,530 | -12,636 | -18,412 |
| Net Income Continuous | -16,551 | -2,334 | -16,530 | -12,636 | -18,412 |
| Net Income | $-16,551 | $-2,334 | $-16,530 | $-12,636 | $-18,412 |
| EPS Basic Total Ops | -0.49 | -0.07 | -0.49 | -0.46 | -0.74 |
| EPS Basic Continuous Ops | -0.49 | -0.07 | -0.49 | -0.47 | -0.74 |
| EPS Diluted Total Ops | -0.49 | -0.07 | -0.49 | -0.46 | -0.74 |
| EPS Diluted Continuous Ops | -0.49 | -0.07 | -0.49 | -0.47 | -0.74 |
| EBITDA(a) | $-12,537 | $1,775 | $-12,390 | $-8,696 | $-9,700 |